August 15, 2022 /

Restoring Dystrophin via Exon Skipping Strategies — PPMD 2022 Annual Conference

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Restoring Dystrophin via Exon Skipping Strategies

AOC 1044 – Mark Stahl, MD (Avidity Biosciences)
BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.)
DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics)
ED051 – Michelle Mellion, MD (PepGen, Inc.)
ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics)
SRP-5051 – Teji Singh, MD (Sarepta Therapeutics)
WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences)

2022 PPMD Annual Conference,
Conferences & Meetings

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo